Owing to the recent approval of therapies, such as Elzonris®, Pluvicto®, there has been a substantial increase in the R&D activity to evaluate the use of novel antibody therapy candidates for the treatment of a variety of disease indications Roots Analysis has announced the addition of “Novel Antibody Therapies Market, 2022-2035” report to its list…